Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

Journal: Science Translational Medicine

Published: 2020-10-28

DOI: 10.1126/scitranslmed.abb8969

Affiliations: 16

Authors: 25

Go to article
Institutions Share
Faculty of Medicine, Uni Freiburg, Germany 0.33
Department of Immunometabolism, MPI-IE, Germany 0.18
Institute of Molecular Biology and Biochemistry (MBBC), Med Uni Graz, Austria 0.06
DKTK Partner Site Essen/Düsseldorf, Germany 0.06
Institute of Molecular Medicine and Cell Research, Uni Freiburg, Germany 0.06
Faculty of Biology, Uni Freiburg, Germany 0.04
University Medical Center Freiburg, Germany 0.04
University of Freiburg (Uni Freiburg), Germany 0.04
Division of Blood and Marrow Transplantation, UMN, United States of America (USA) 0.04
Cluster of Excellence - Center for Biological Signalling Studies (BIOSS), Uni Freiburg, Germany 0.03
Cluster of Excellence - Centre for Integrative Biological Signalling Studies (CIBSS), Uni Freiburg, Germany 0.03
Sloan Kettering Institute (SKI), MSKCC, United States of America (USA) 0.02
Department of Internal Medicine III, UR, Germany 0.02
Regensburg Centre for Interventional Immunology (RCI), UR, Germany 0.02
BioTechMed-Graz, Austria 0.02
Institute of Neuropathology, Uni Freiburg, Germany 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER